Form 4 Tracker
Vera Therapeutics, Inc.
VERA

36 insider filings · Latest: Sep 15, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Sep 15, 2026Sep 17 8:28 PMMarshall FordyceDirector, PRESIDENT AND CEO
Sale
18,500$37.00$684.5K235,244(D)

View →

Sep 2, 2026Sep 4 8:15 PMMarshall FordyceDirector, PRESIDENT AND CEO
Sale
18,500$35.12$649.6K235,244(D)

View →

Sep 2, 2026Sep 2 8:32 PMMARSHALL FORDYCE
Proposed Sale
64,750$34.23$2.2M—

View →

Jul 7, 2026Aug 12 10:42 PMMarshall FordyceDirector, PRESIDENT AND CEO
Sale
46,250$42.30$2.0M235,244(D)

View →

Jun 23, 2026Aug 12 10:41 PMMarshall FordyceDirector, PRESIDENT AND CEO
Sale
18,500$37.93$701.8K235,244(D)

View →

May 12, 2026Aug 12 10:39 PMMarshall FordyceDirector, PRESIDENT AND CEO
Sale
18,500$36.74$679.7K235,244(D)

View →

Jul 7, 2026Jul 9 8:45 PMMarshall FordyceDirector, PRESIDENT AND CEO
Sale
46,250$42.30$2.0M151,994(D)

View →

Jun 23, 2026Jun 24 8:55 PMMarshall FordyceDirector, PRESIDENT AND CEO
Sale
18,500$37.93$701.8K198,244(D)

View →

Jun 23, 2026Jun 23 8:29 PMMARSHALL FORDYCE
Proposed Sale
74,000$38.43$2.8M—

View →

May 12, 2026May 13 8:26 PMMarshall FordyceDirector, PRESIDENT AND CEO
Sale
18,500$36.74$679.7K216,744(D)

View →

May 12, 2026May 12 8:33 PMMARSHALL FORDYCE
Proposed Sale
18,500$36.61$677.3K—

View →

Apr 14, 2026Apr 15 8:57 PMMarshall FordyceDirector, PRESIDENT AND CEO
Sale
22,951$44.05$1.0M235,244(D)

View →

Apr 14, 2026Apr 14 8:33 PMMARSHALL FORDYCE
Proposed Sale
22,951$43.71$1.0M—

View →

Feb 23, 2026Feb 26 1:01 AMRobert BrennerChief Medical Officer
Sale
2,151$41.98$90.3K50,947(D)

View →

Feb 23, 2026Feb 26 1:00 AMJoseph R YoungSVP, FINANCE, CHIEF ACCT OFFCR
Sale
3,117$41.98$130.9K64,722(D)

View →

Feb 23, 2026Feb 26 12:59 AMSean GrantCHIEF FINANCIAL OFFICER
Sale
4,949$41.98$207.8K114,181(D)

View →

Feb 23, 2026Feb 26 12:58 AMMarshall FordyceDirector, PRESIDENT AND CEO
Sale
16,925$41.98$710.6K257,163(D)

View →

Feb 23, 2026Feb 26 12:57 AMDavid Lee JohnsonChief Operating Officer
Sale
2,579$41.98$108.3K45,727(D)

View →

Feb 23, 2026Feb 26 12:56 AMWilliam D. TurnerChief Regulatory Officer
Sale
2,187$41.98$91.8K45,313(D)

View →

Feb 23, 2026Feb 26 12:53 AMLaurence Matthew SkeltonChief Commercial Officer
Sale
1,582$41.98$66.4K64,218(D)

View →

Page 1 of 3

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Sep 15, 2026Sep 17 8:28 PMMarshall FordyceDirector, PRESIDENT AND CEO
Option Exercise
18,500$2.90488,801(D)

View →

Sep 11, 2026Sep 14 8:28 PMJoseph R YoungSVP, FINANCE, CHIEF ACCT OFFCR
Option Exercise
5,000$3.9433,589(D)

View →

Sep 2, 2026Sep 4 8:15 PMMarshall FordyceDirector, PRESIDENT AND CEO
Option Exercise
18,500$2.90507,301(D)

View →

Jul 7, 2026Aug 12 10:42 PMMarshall FordyceDirector, PRESIDENT AND CEO
Option Exercise
46,250$2.90525,801(D)

View →

Jun 23, 2026Aug 12 10:41 PMMarshall FordyceDirector, PRESIDENT AND CEO
Option Exercise
18,500$2.90572,051(D)

View →

May 12, 2026Aug 12 10:39 PMMarshall FordyceDirector, PRESIDENT AND CEO
Option Exercise
18,500$2.90590,551(D)

View →

Aug 3, 2026Aug 5 8:14 PMNancy Lee BomanChief Regulatory Officer
Grant/Award
63,011$32.2363,011(D)

View →

May 21, 2026May 26 8:24 PMScott W MorrisonDirector
Grant/Award
17,084$34.3517,084(D)

View →

May 21, 2026May 26 8:22 PMAndrew ChengDirector
Grant/Award
17,084$34.3517,084(D)

View →

May 21, 2026May 26 8:22 PMBeth C SeidenbergDirector
Grant/Award
17,084$34.3517,084(D)

View →

May 21, 2026May 26 8:20 PMChristy J. OligerDirector
Grant/Award
17,084$34.3517,084(D)

View →

May 21, 2026May 26 8:19 PMJames R MeyersDirector
Grant/Award
17,084$34.3517,084(D)

View →

May 21, 2026May 26 8:18 PMKimball HallDirector
Grant/Award
17,084$34.3517,084(D)

View →

May 21, 2026May 26 8:17 PMMichael MorrisseyDirector
Grant/Award
17,084$34.3517,084(D)

View →

May 21, 2026May 26 8:15 PMPatrick G EnrightDirector
Grant/Award
17,084$34.3517,084(D)

View →

Mar 23, 2026Mar 25 11:08 PMJane Wright-MitchellChief Legal Officer
Grant/Award
56,850$40.7356,850(D)

View →

Mar 13, 2026Mar 16 10:52 PMJoseph R YoungSVP, FINANCE, CHIEF ACCT OFFCR
Option Exercise
10,000$3.9438,589(D)

View →

Mar 5, 2026Mar 9 8:49 PMChristopher HiteDirector
Grant/Award
24,937$38.8524,937(D)

View →

Feb 4, 2026Feb 7 1:00 AMJoseph R YoungSVP, FINANCE, CHIEF ACCT OFFCR
Grant/Award
20,000$42.7420,000(D)

View →

Feb 4, 2026Feb 7 1:00 AMMarshall FordyceDirector, PRESIDENT AND CEO
Grant/Award
137,500$42.74137,500(D)

View →

Page 1 of 2

Next →